SCHEMBL23529314

SCHEMBL23529314

COc1c(C(N)=O)ccc2c1nc(-c1c(F)cc(F)cc1-c1nn[nH]n1)n2CCn1c(-c2c(F)cc(F)cc2-c2nn[nH]n2)nc2c(OC)c(C(N)=O)ccc21

nearest known ligand 0.36

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 3/20 0.36
ACSS2 Q9NR19 1/20 0.35
SCN9A Q15858 1/20 0.34
PARP1 P09874 1/20 0.33
PKN1 Q16512 1/20 0.33
PKN2 Q16513 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
PTGER4 P35408 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29948208 1.00 GPR35 (0.36) GPR35ACSS2SCN9APARP1PKN1
SCHEMBL23529396 0.92 GPR35 (0.35) GPR35ACSS2PARP1PKN1PKN2
SCHEMBL29948116 0.92 GPR35 (0.35) GPR35ACSS2PARP1PKN1PKN2
SCHEMBL23552508 0.92 GPR35 (0.32) GPR35ACSS2PTGER4
SCHEMBL23529304 0.89 ACSS2 (0.39) ACSS2PARP1PKN1PKN2
SCHEMBL29948221 0.89 ACSS2 (0.39) ACSS2PARP1PKN1PKN2
SCHEMBL24801692 0.85 GPR35 (0.31) GPR35ACSS2
SCHEMBL23552513 0.84 GPR35 (0.31) GPR35ACSS2
SCHEMBL23529398 0.83 PTGER4 (0.38) PTGER4
SCHEMBL23529311 0.83 AGTR1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132112-A1 COMPOUNDS CTXT PTY LTD (AU) 2026-05-14 US claimed
EP-4077318-B1 BENZIMIDAZOLE DIMERS AS MODULATORS OF STING CTXT PTY LTD (AU) 2025-10-15 EP claimed
US-12415785-B2 Compound modulators of sting CTXT PTY LTD (AU) 2025-09-16 US claimed
US-20230062932-A1 COMPOUNDS CTXT PTY LTD. (AU) 2023-03-02 US claimed
CN-114981265-A Compound (I) CTXT私人有限公司 2022-08-30 CN claimed
US-20260132112-A1 COMPOUNDS CTXT PTY LTD (AU) 2026-05-14 US disclosed
EP-4077318-B1 BENZIMIDAZOLE DIMERS AS MODULATORS OF STING CTXT PTY LTD (AU) 2025-10-15 EP disclosed
US-12415785-B2 Compound modulators of sting CTXT PTY LTD (AU) 2025-09-16 US disclosed
US-20230062932-A1 COMPOUNDS CTXT PTY LTD. (AU) 2023-03-02 US disclosed
US-20230062932-A1 COMPOUNDS CTXT PTY LTD. (AU) 2023-03-02 US disclosed
CN-114981265-A Compound (I) CTXT私人有限公司 2022-08-30 CN disclosed
WO-2021119753-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2021-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415785-B2 Compound modulators of sting STING1, IRF3, MAVS GPR35 1670/4885ACSS2 2077/4885SCN9A 3398/4885
US-20260132112-A1 COMPOUNDS STING1, IRF3, CGAS GPR35 1499/4885ACSS2 2968/4885SCN9A 3979/4885
US-20230062932-A1 COMPOUNDS STING1, IRF3, MAVS GPR35 1562/4885ACSS2 1883/4885SCN9A 3260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.